Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line

BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide with a poor prognosis. Human papilloma virus (HPV) infection is associated with 20% HNSCC, and 50% of oropharyngeal carcinoma. HPV16 type is detected in 90% of all HPV+ HNSCC. Recently we suggeste...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Matthew, Wang, Xing Guo, Jiang, Zewei, Goldberg, Gary L, Casadevall, Arturo, Dadachova, Ekaterina
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046925/
https://www.ncbi.nlm.nih.gov/pubmed/21314983
http://dx.doi.org/10.1186/1758-3284-3-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046925/
https://www.ncbi.nlm.nih.gov/pubmed/21314983
http://dx.doi.org/10.1186/1758-3284-3-9

Ejemplares similares